Obamacare’s uncertain future as we enter the third year of Trump’s presidency

The prevalence of childhood blindness is much higher in developing countries – and it is largely avoidable

When a patient comes to us with a calcified IOL, all is not lost. The solution is clear, but it requires care and skill

Our newfound ability to harness the power of gene therapy is facing an age-old challenge: financial constraints

12 surgeons provide a counterpoint to George Beiko’s controversial take on refractive lens exchange.

The research tackling the pressing and substantial need for new gene medications targeting conventional aqueous outflow

Why FLACS is the way forward for Fuchs dystrophy patients in need of cataract extraction

A fresh take on our Power List brings a five-fold increase in the number of votes – and many new faces

As you nominate your colleagues for the 2019 Power List, consider the wider impact of your choice.

Can the NHS keep up with demand for consumables in the event of a "no-deal" Brexit?